ClinicalMetric / Countries / Poland / hip osteoarthritis
← 🇵🇱 Poland Trials
🇵🇱 Poland Country × Condition

hip osteoarthritis Clinical Trials in Poland

Active clinical trials for hip osteoarthritis with research sites in Poland. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 2 // Recruiting: 2 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇵🇱 Poland

Active Trials in Poland (2)

NCT07581470
Recruiting

Intravenous Dexamethasone (0 vs 4 vs 8 mg) as an Adjunct to PENG Block for Postoperative Analgesia in Total Hip Arthroplasty

Enrollment
198 pts
Country
🇵🇱 Poland
Poznan University of Medical Scienc...
View Trial →
NCT07327892
Recruiting

PENG Block vs PENG Plus Periarticular Injection vs Periarticular Injection in Older Adults

Enrollment
108 pts
Country
🇵🇱 Poland
Poznan University of Medical Scienc...
View Trial →

Frequently Asked Questions

How many hip osteoarthritis clinical trials are active in Poland?
There are currently 2 active clinical trials for hip osteoarthritis with sites in Poland, of which 2 are actively recruiting patients.
How can I join a hip osteoarthritis clinical trial in Poland?
To join a hip osteoarthritis clinical trial in Poland, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Poland directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are hip osteoarthritis trials in Poland?
Active hip osteoarthritis trials in Poland span multiple phases. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Poland Trials → Global hip osteoarthritis Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology